ArticleBMC sports science, medicine & rehabilitation2026
The effects of combined functional and aerobic training along with folic acid supplementation on serum levels of Isthmin-1, inflammatory markers and insulin resistance in men with obesity.
Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a complex systemic metabolic disorder characterized by chronic low-grade inflammation and insulin resistance. This study aimed to investigate the effects of a 12-week intervention combining functional and aerobic training with folic acid supplementation on serum levels of Isthmin-1 (ISM1), key inflammatory markers (MCP-1, TNF-α, IL-6), and insulin resistance in young men with obesity.
methodsIn this double-blind randomized experimental trial, 44 men with obesity (age: 23-32 years, BMI ≥ 30 kg/m²) were randomly allocated into four equal groups (n = 11 per group): Control (CG), Folic Acid Supplementation (S), Combined Training (CT), and Combined Training + Supplementation (CTS). The training protocol consisted of 12 weeks of progressive functional exercises (focusing on stability, strength, and interval training) combined with treadmill-based aerobic exercise. The supplemented groups consumed 500 μg of folic acid daily. Blood samples were collected 48 h before the initiation and 48 h after the completion of the 12-week intervention to assess biochemical, inflammatory, and glycemic indices. Data were analyzed using a 2×4 mixed-design repeated measures ANOVA, followed by Bonferroni post-hoc pairwise comparisons, with the significance level set at P < 0.05.
resultsBody weight and BMI decreased significantly only in the CTS group (P = 0.001). While both the CT and CTS groups exhibited significant reductions in body fat percentage and fat mass, the magnitude of these reductions was significantly greater in the CTS group (P = 0.001). Regarding glycemic control, all three active intervention groups (S, CT, and CTS) demonstrated significant reductions in fasting glucose, insulin, and HOMA-IR, with the most pronounced improvements observed in the CTS group (P < 0.05). Serum ISM1 levels increased significantly in both the CT and CTS groups (P < 0.05), whereas serum levels of MCP-1, TNF-α, and IL-6 decreased significantly in all three intervention groups (P = 0.001). Furthermore, serum ISM1 levels exhibited a significant inverse correlation with both inflammatory markers and insulin resistance indices.
conclusionsThe findings suggest that 12 weeks of combined functional and aerobic training with folic acid supplementation may offer potential benefits for improving metabolic status and insulin sensitivity in obese men; however, these preliminary outcomes should be interpreted with caution due to the limited sample size.
trial registrationhttps://www.ncbi.nlm.nih.gov/mesh/68009765 . https://www.ncbi.nlm.nih.gov/mesh/68015444 . https://www.ncbi.nlm.nih.gov/mesh/68005492 . https://www.ncbi.nlm.nih.gov/mesh/68007249 . https://www.ncbi.nlm.nih.gov/mesh/68007333 . https://www.ncbi.nlm.nih.gov/mesh/2007061 . The trial was prospectively registered at the Iranian Registry of Clinical Trials ( https://fa.irct.ir/trial/87438 (accessed on 26 November 2025) under registration number (IRCT20120129008863N15).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.